DOC1021 is a first-in-class, patient-derived double-loaded dendritic cell therapy that combines tumor lysate and amplified tumor-derived mRNA. The immunotherapy is made with a patient's dendritic ...
Dehradun: A delegation of 40 civil service officers from Sri Lanka visited the State Emergency Operations Centre (SEOC) in ...
New blinded data from ~45 patients to date in key pain and function scales and safety and tolerability of the Company’s ...
Per-protocol survival improved versus earlier cutoffs, with 35% alive beyond 30 months and 13% beyond 50 months after two ...
In the high-stakes arena of global business, elite specialists often hit an invisible ceiling. They achieve “local hero” status—dominating regional markets through years of practical excellence—yet ...
BV500: Entered global research collaboration with Shionogi for broad-spectrum non-tuberculous mycobacteria Successful IPO funding operations into 2028 with BV100 Phase 3 read-out by the end of 2027 ...
At the heart of this challenge is the HDMI extender—a sophisticated device designed to overcome the physical limitations of standard copper cabling. As a China Leading HDMI Extender Manufacturer, ...
Oceanside, CA - March 18, 2026 - PRESSADVANTAGE - Moment of Clarity has released a new educational resource examining ...
3d
Kyntra Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Phase 2 monotherapy trial of FG-3246, a potential first-in-class antibody drug conjugate (ADC) targeting CD46, in metastatic castration-resistant ...
The 12th Welfare and Safety of the Racehorse Summit will be hosted by Keeneland June 29-30. The event will be sponsored by ...
Lundbeck Advances Parkinson's Research With New Phase 1B Data At AD/PDTM 2026. Phase 1b data on Lu AF28996, an investigational treatment for people with advanced Parkinson's disease, to be presented ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results